Keith Jason August MD
Professor of Pediatrics, University of Missouri-Kansas City School of Medicine
Join to View Full Profile
2401 Gillham Rd.Kansas City, MO 64108
Dr. August is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
University of Louisville School of MedicineResidency, Pediatrics, 2002 - 2005
University of Oklahoma College of MedicineClass of 2002
Certifications & Licensure
MO State Medical License 2009 - 2027
KS State Medical License 2011 - 2026
GA State Medical License 2005 - 2011
OK State Medical License 2009 - 2010
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Start of enrollment: 2015 Jul 01
- A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
- A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer Start of enrollment: 2016 Aug 29
Publications & Presentations
PubMed
- Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohort.Lisa A Lansdon, Byunggil Yoo, Ayse Keskus, Irina Pushel, Chengpeng Bi
NPJ Genomic Medicine. 2026-04-09 - The Power of Parenting: Longitudinal Associations Between Psychosocial Distress, Family Rules, Routines, and Child Emotional and Behavioral Health During Pediatric Can...Carolyn R Bates, Renee M Gilbert, Emily Cramer, Kelsey M Dean, Keith J August
Pediatric Blood & Cancer. 2026-03-01 - 7 citationsPediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers
Blood Advances. 2025-03-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
